HEADER TRANSFERASE 19-FEB-15 4YC4 TITLE CRYSTAL STRUCTURE OF PHOSPHATIDYL INOSITOL 4-KINASE II ALPHA IN TITLE 2 COMPLEX WITH NUCLEOTIDE ANALOG COMPND MOL_ID: 1; COMPND 2 MOLECULE: PHOSPHATIDYLINOSITOL 4-KINASE TYPE 2-ALPHA,LYSOZYME, COMPND 3 PHOSPHATIDYLINOSITOL 4-KINASE TYPE 2-ALPHA; COMPND 4 CHAIN: A; COMPND 5 SYNONYM: PHOSPHATIDYLINOSITOL 4-KINASE TYPE II-ALPHA, COMPND 6 PHOSPHATIDYLINOSITOL 4-KINASE TYPE II-ALPHA; COMPND 7 EC: 2.7.1.67,3.2.1.17,2.7.1.67; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS, ENTEROBACTERIA PHAGE T4; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606, 10665; SOURCE 5 GENE: PI4K2A, T4TP126; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: STAR; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PRSFD KEYWDS KINASE, COMPLEX, INHIBITOR, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR M.KLIMA,E.BOURA REVDAT 2 06-SEP-17 4YC4 1 SITE ATOM REVDAT 1 15-JUL-15 4YC4 0 JRNL AUTH M.KLIMA,A.BAUMLOVA,D.CHALUPSKA,H.HREBABECKY,M.DEJMEK, JRNL AUTH 2 R.NENCKA,E.BOURA JRNL TITL THE HIGH-RESOLUTION CRYSTAL STRUCTURE OF JRNL TITL 2 PHOSPHATIDYLINOSITOL 4-KINASE II BETA AND THE CRYSTAL JRNL TITL 3 STRUCTURE OF PHOSPHATIDYLINOSITOL 4-KINASE II ALPHA JRNL TITL 4 CONTAINING A NUCLEOSIDE ANALOGUE PROVIDE A STRUCTURAL BASIS JRNL TITL 5 FOR ISOFORM-SPECIFIC INHIBITOR DESIGN. JRNL REF ACTA CRYSTALLOGR.,SECT.D V. 71 1555 2015 JRNL REFN ESSN 1399-0047 JRNL PMID 26143926 JRNL DOI 10.1107/S1399004715009505 REMARK 2 REMARK 2 RESOLUTION. 2.58 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.8_1069) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.58 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 49.07 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 95.8 REMARK 3 NUMBER OF REFLECTIONS : 20124 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.216 REMARK 3 R VALUE (WORKING SET) : 0.214 REMARK 3 FREE R VALUE : 0.256 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1007 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 49.0770 - 4.9281 0.99 2983 158 0.1949 0.2297 REMARK 3 2 4.9281 - 3.9121 1.00 2872 151 0.1816 0.1954 REMARK 3 3 3.9121 - 3.4178 1.00 2836 149 0.2054 0.2629 REMARK 3 4 3.4178 - 3.1053 1.00 2823 149 0.2385 0.3161 REMARK 3 5 3.1053 - 2.8828 1.00 2794 147 0.2584 0.3123 REMARK 3 6 2.8828 - 2.7128 0.95 2651 139 0.2677 0.3143 REMARK 3 7 2.7128 - 2.5770 0.77 2158 114 0.2915 0.3657 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.330 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 30.310 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.012 4022 REMARK 3 ANGLE : 1.672 5466 REMARK 3 CHIRALITY : 0.106 595 REMARK 3 PLANARITY : 0.012 703 REMARK 3 DIHEDRAL : 16.084 1500 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4YC4 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 19-FEB-15. REMARK 100 THE DEPOSITION ID IS D_1000207180. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 23-JAN-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : BESSY REMARK 200 BEAMLINE : 14.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.918409 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : PSI PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20124 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.580 REMARK 200 RESOLUTION RANGE LOW (A) : 49.070 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.8 REMARK 200 DATA REDUNDANCY : 3.700 REMARK 200 R MERGE (I) : 0.07140 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 15.9800 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.58 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.67 REMARK 200 COMPLETENESS FOR SHELL (%) : 74.2 REMARK 200 DATA REDUNDANCY IN SHELL : 2.60 REMARK 200 R MERGE FOR SHELL (I) : 0.40400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.360 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.66 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.54 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM HEPES PH = 7.0, 10% W/V PEG REMARK 280 4000, 10% V/V 2-PROPANOL, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 39.70700 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 51.88500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 39.70700 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 51.88500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 550 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 24000 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 1.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 72 REMARK 465 ALA A 73 REMARK 465 MET A 74 REMARK 465 GLY A 75 REMARK 465 THR A 76 REMARK 465 VAL A 77 REMARK 465 ALA A 78 REMARK 465 ALA A 79 REMARK 465 GLN A 80 REMARK 465 ALA A 81 REMARK 465 GLN A 82 REMARK 465 ALA A 83 REMARK 465 LEU A 84 REMARK 465 ALA A 85 REMARK 465 ALA A 86 REMARK 465 GLN A 87 REMARK 465 ALA A 88 REMARK 465 ALA A 89 REMARK 465 ALA A 90 REMARK 465 ALA A 91 REMARK 465 ALA A 92 REMARK 465 HIS A 93 REMARK 465 ALA A 94 REMARK 465 ALA A 95 REMARK 465 GLN A 96 REMARK 465 ALA A 97 REMARK 465 HIS A 98 REMARK 465 ARG A 99 REMARK 465 GLU A 100 REMARK 465 LYS A 234 REMARK 465 ARG A 235 REMARK 465 LEU A 236 REMARK 465 ALA A 237 REMARK 465 LEU A 238 REMARK 465 GLU A 239 REMARK 465 LYS A 240 REMARK 465 VAL A 241 REMARK 465 PRO A 242 REMARK 465 LYS A 243 REMARK 465 VAL A 244 REMARK 465 GLY A 245 REMARK 465 GLN A 246 REMARK 465 ARG A 247 REMARK 465 PHE A 248 REMARK 465 ASN A 249 REMARK 465 CYS A 320 REMARK 465 PRO A 321 REMARK 465 MET A 322 REMARK 465 ASP A 323 REMARK 465 SER A 324 REMARK 465 SER A 325 REMARK 465 SER A 326 REMARK 465 SER A 327 REMARK 465 ARG A 328 REMARK 465 ASP A 329 REMARK 465 THR A 330 REMARK 465 ARG A 455 REMARK 465 SER A 456 REMARK 465 HIS A 457 REMARK 465 GLN A 458 REMARK 465 ARG A 459 REMARK 465 SER A 460 REMARK 465 SER A 461 REMARK 465 SER A 462 REMARK 465 GLU A 463 REMARK 465 SER A 464 REMARK 465 TYR A 465 REMARK 465 THR A 466 REMARK 465 GLN A 467 REMARK 465 SER A 468 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 101 CG CD NE CZ NH1 NH2 REMARK 470 TYR A 131 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 TYR A 159 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 LYS A 165 CG CD CE NZ REMARK 470 LYS A 172 CG CD CE NZ REMARK 470 ARG A1139 CG CD NE CZ NH1 NH2 REMARK 470 LYS A1164 CG CD CE NZ REMARK 470 ASN A1165 CG OD1 ND2 REMARK 470 LEU A1166 CG CD1 CD2 REMARK 470 ARG A 181 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 265 CG CD OE1 OE2 REMARK 470 LYS A 336 CG CD CE NZ REMARK 470 TYR A 365 CG CD1 CD2 CE1 CE2 CZ OH REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE1 GLU A 398 NH2 ARG A 424 1.94 REMARK 500 O ARG A 228 OG SER A 231 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 NH2 ARG A 1078 OE2 GLU A 379 1556 2.08 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 CYS A 183 CB CYS A 183 SG -0.106 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A1126 -2.04 79.66 REMARK 500 TYR A1141 -52.09 73.53 REMARK 500 ASN A1165 57.08 -146.82 REMARK 500 ARG A 181 -76.06 -88.51 REMARK 500 ASP A 182 -0.02 71.99 REMARK 500 LYS A 354 163.25 178.30 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 SER A 134 SER A 135 -139.00 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue M59 A 1201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ADP A 1202 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4PLA RELATED DB: PDB REMARK 900 4PLA CONTAINS THE SAME PROTEIN COMPLEXED WITH ATP DBREF 4YC4 A 76 172 UNP Q9BTU6 P4K2A_HUMAN 76 172 DBREF 4YC4 A 1004 1166 UNP D9IEF7 D9IEF7_BPT4 2 164 DBREF 4YC4 A 180 468 UNP Q9BTU6 P4K2A_HUMAN 180 468 SEQADV 4YC4 GLY A 72 UNP Q9BTU6 EXPRESSION TAG SEQADV 4YC4 ALA A 73 UNP Q9BTU6 EXPRESSION TAG SEQADV 4YC4 MET A 74 UNP Q9BTU6 EXPRESSION TAG SEQADV 4YC4 GLY A 75 UNP Q9BTU6 EXPRESSION TAG SEQADV 4YC4 GLY A 1001 UNP Q9BTU6 LINKER SEQADV 4YC4 THR A 1002 UNP Q9BTU6 LINKER SEQADV 4YC4 GLY A 1003 UNP Q9BTU6 LINKER SEQADV 4YC4 THR A 1056 UNP D9IEF7 CYS 54 CONFLICT SEQADV 4YC4 ALA A 1099 UNP D9IEF7 CYS 97 CONFLICT SEQRES 1 A 556 GLY ALA MET GLY THR VAL ALA ALA GLN ALA GLN ALA LEU SEQRES 2 A 556 ALA ALA GLN ALA ALA ALA ALA ALA HIS ALA ALA GLN ALA SEQRES 3 A 556 HIS ARG GLU ARG ASN GLU PHE PRO GLU ASP PRO GLU PHE SEQRES 4 A 556 GLU ALA VAL VAL ARG GLN ALA GLU LEU ALA ILE GLU ARG SEQRES 5 A 556 CYS ILE PHE PRO GLU ARG ILE TYR GLN GLY SER SER GLY SEQRES 6 A 556 SER TYR PHE VAL LYS ASP PRO GLN GLY ARG ILE ILE ALA SEQRES 7 A 556 VAL PHE LYS PRO LYS ASN GLU GLU PRO TYR GLY HIS LEU SEQRES 8 A 556 ASN PRO LYS TRP THR LYS TRP LEU GLN LYS GLY THR GLY SEQRES 9 A 556 ASN ILE PHE GLU MET LEU ARG ILE ASP GLU GLY LEU ARG SEQRES 10 A 556 LEU LYS ILE TYR LYS ASP THR GLU GLY TYR TYR THR ILE SEQRES 11 A 556 GLY ILE GLY HIS LEU LEU THR LYS SER PRO SER LEU ASN SEQRES 12 A 556 ALA ALA LYS SER GLU LEU ASP LYS ALA ILE GLY ARG ASN SEQRES 13 A 556 THR ASN GLY VAL ILE THR LYS ASP GLU ALA GLU LYS LEU SEQRES 14 A 556 PHE ASN GLN ASP VAL ASP ALA ALA VAL ARG GLY ILE LEU SEQRES 15 A 556 ARG ASN ALA LYS LEU LYS PRO VAL TYR ASP SER LEU ASP SEQRES 16 A 556 ALA VAL ARG ARG ALA ALA LEU ILE ASN MET VAL PHE GLN SEQRES 17 A 556 MET GLY GLU THR GLY VAL ALA GLY PHE THR ASN SER LEU SEQRES 18 A 556 ARG MET LEU GLN GLN LYS ARG TRP ASP GLU ALA ALA VAL SEQRES 19 A 556 ASN LEU ALA LYS SER ARG TRP TYR ASN GLN THR PRO ASN SEQRES 20 A 556 ARG ALA LYS ARG VAL ILE THR THR PHE ARG THR GLY THR SEQRES 21 A 556 TRP ASP ALA TYR LYS ASN LEU GLY ARG ASP CYS LEU VAL SEQRES 22 A 556 LEU ASN GLN GLY TYR LEU SER GLU ALA GLY ALA SER LEU SEQRES 23 A 556 VAL ASP GLN LYS LEU GLU LEU ASN ILE VAL PRO ARG THR SEQRES 24 A 556 LYS VAL VAL TYR LEU ALA SER GLU THR PHE ASN TYR SER SEQRES 25 A 556 ALA ILE ASP ARG VAL LYS SER ARG GLY LYS ARG LEU ALA SEQRES 26 A 556 LEU GLU LYS VAL PRO LYS VAL GLY GLN ARG PHE ASN ARG SEQRES 27 A 556 ILE GLY LEU PRO PRO LYS VAL GLY SER PHE GLN LEU PHE SEQRES 28 A 556 VAL GLU GLY TYR LYS ASP ALA ASP TYR TRP LEU ARG ARG SEQRES 29 A 556 PHE GLU ALA GLU PRO LEU PRO GLU ASN THR ASN ARG GLN SEQRES 30 A 556 LEU LEU LEU GLN PHE GLU ARG LEU VAL VAL LEU ASP TYR SEQRES 31 A 556 ILE ILE ARG ASN THR ASP ARG GLY ASN ASP ASN TRP LEU SEQRES 32 A 556 ILE LYS TYR ASP CYS PRO MET ASP SER SER SER SER ARG SEQRES 33 A 556 ASP THR ASP TRP VAL VAL VAL LYS GLU PRO VAL ILE LYS SEQRES 34 A 556 VAL ALA ALA ILE ASP ASN GLY LEU ALA PHE PRO LEU LYS SEQRES 35 A 556 HIS PRO ASP SER TRP ARG ALA TYR PRO PHE TYR TRP ALA SEQRES 36 A 556 TRP LEU PRO GLN ALA LYS VAL PRO PHE SER GLN GLU ILE SEQRES 37 A 556 LYS ASP LEU ILE LEU PRO LYS ILE SER ASP PRO ASN PHE SEQRES 38 A 556 VAL LYS ASP LEU GLU GLU ASP LEU TYR GLU LEU PHE LYS SEQRES 39 A 556 LYS ASP PRO GLY PHE ASP ARG GLY GLN PHE HIS LYS GLN SEQRES 40 A 556 ILE ALA VAL MET ARG GLY GLN ILE LEU ASN LEU THR GLN SEQRES 41 A 556 ALA LEU LYS ASP ASN LYS SER PRO LEU HIS LEU VAL GLN SEQRES 42 A 556 MET PRO PRO VAL ILE VAL GLU THR ALA ARG SER HIS GLN SEQRES 43 A 556 ARG SER SER SER GLU SER TYR THR GLN SER HET M59 A1201 19 HET ADP A1202 39 HETNAM M59 [(1S,3S,4S)-3-(6-AMINO-9H-PURIN-9-YL) HETNAM 2 M59 BICYCLO[2.2.1]HEPT-1-YL]METHANOL HETNAM ADP ADENOSINE-5'-DIPHOSPHATE FORMUL 2 M59 C13 H17 N5 O FORMUL 3 ADP C10 H15 N5 O10 P2 FORMUL 4 HOH *3(H2 O) HELIX 1 AA1 ASP A 107 ARG A 123 1 17 HELIX 2 AA2 ASN A 155 GLU A 157 5 3 HELIX 3 AA3 ASN A 163 LYS A 172 1 10 HELIX 4 AA4 GLY A 1001 GLY A 1003 5 3 HELIX 5 AA5 ASN A 1004 GLY A 1014 1 11 HELIX 6 AA6 SER A 1040 GLY A 1053 1 14 HELIX 7 AA7 THR A 1061 ARG A 1082 1 22 HELIX 8 AA8 LYS A 1085 LEU A 1093 1 9 HELIX 9 AA9 ASP A 1094 MET A 1108 1 15 HELIX 10 AB1 MET A 1108 ALA A 1114 1 7 HELIX 11 AB2 PHE A 1116 LYS A 1126 1 11 HELIX 12 AB3 ARG A 1127 LEU A 1135 1 9 HELIX 13 AB4 SER A 1138 GLN A 1143 1 6 HELIX 14 AB5 THR A 1144 THR A 1157 1 14 HELIX 15 AB6 TRP A 1160 LYS A 1164 5 5 HELIX 16 AB7 GLN A 188 GLU A 204 1 17 HELIX 17 AB8 SER A 224 SER A 231 1 8 HELIX 18 AB9 ALA A 270 GLU A 280 1 11 HELIX 19 AC1 PRO A 283 ARG A 305 1 23 HELIX 20 AC2 PHE A 364 VAL A 374 5 11 HELIX 21 AC3 SER A 377 SER A 389 1 13 HELIX 22 AC4 ASP A 390 LYS A 406 1 17 HELIX 23 AC5 ASP A 412 ASP A 436 1 25 HELIX 24 AC6 SER A 439 MET A 446 1 8 SHEET 1 AA1 5 GLU A 128 ARG A 129 0 SHEET 2 AA1 5 TYR A 138 LYS A 141 -1 O PHE A 139 N GLU A 128 SHEET 3 AA1 5 ILE A 147 PRO A 153 -1 O ALA A 149 N VAL A 140 SHEET 4 AA1 5 LYS A 256 LEU A 262 -1 O GLN A 261 N VAL A 150 SHEET 5 AA1 5 THR A 211 LEU A 216 -1 N LEU A 216 O LYS A 256 SHEET 1 AA2 3 ARG A1016 LYS A1021 0 SHEET 2 AA2 3 TYR A1027 GLY A1030 -1 O THR A1028 N TYR A1020 SHEET 3 AA2 3 HIS A1033 THR A1036 -1 O LEU A1035 N TYR A1027 SHEET 1 AA3 3 LYS A 268 ASP A 269 0 SHEET 2 AA3 3 TRP A 314 TYR A 318 -1 O ILE A 316 N LYS A 268 SHEET 3 AA3 3 ILE A 340 ALA A 344 -1 O ALA A 343 N LEU A 315 CISPEP 1 LEU A 1166 GLY A 180 0 -9.58 SITE 1 AC1 8 GLN A 132 GLN A 261 LEU A 262 PHE A 263 SITE 2 AC1 8 VAL A 264 ILE A 345 ASP A 346 HOH A1301 SITE 1 AC2 8 TRP A 359 ARG A 360 PRO A 363 PHE A 364 SITE 2 AC2 8 ALA A 367 TRP A 368 VAL A 444 GLN A 445 CRYST1 79.414 103.770 78.109 90.00 90.00 90.00 P 21 21 2 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012592 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009637 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012803 0.00000 MASTER 392 0 2 24 11 0 4 6 0 0 0 43 END